Strata Critical Medical, Inc. - Laporan Laba Rugi (TTM)

Strata Critical Medical, Inc.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Strata Critical Medical, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 23 26 29 39 51 67 85 107 133 146 165 190 216 225 231 238 242 249 251 254
Change (%) 11.79 10.76 32.79 31.14 32.92 25.85 26.84 23.70 10.19 12.76 15.39 13.53 4.33 2.77 3.01 1.44 2.84 1.12 1.14
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 21 22 24 31 40 54 70 91 111 124 138 158 178 183 186 187 186 190 191 192
Change (%) 2.68 8.50 30.22 30.66 35.74 29.30 29.26 22.70 11.21 11.63 14.54 12.26 2.99 1.79 0.52 -0.44 1.77 0.50 0.77
% of Revenue 90.07 82.73 81.04 79.47 79.18 80.86 83.08 84.67 83.98 84.76 83.91 83.29 82.35 81.29 80.51 78.57 77.11 76.31 75.84 75.57
Gross Operating Profit 2 5 6 8 11 13 14 16 21 22 27 32 38 42 45 51 55 59 61 62
Change (%) 94.46 21.59 43.75 32.99 22.20 11.26 14.94 29.23 4.87 19.04 19.83 19.87 10.59 7.06 13.27 8.34 6.47 3.12 2.28
% of Revenue 9.93 17.27 18.96 20.53 20.82 19.14 16.92 15.33 16.02 15.24 16.09 16.71 17.65 18.71 19.49 21.43 22.89 23.69 24.16 24.43
SG&A 12 12 14 22 33 43 53 57 61 67 71 75 82 82 82 92 90 82 82 76
Change (%) -1.64 16.67 64.18 46.57 31.54 24.13 6.30 7.63 10.20 5.10 6.17 9.26 0.27 0.16 11.41 -2.22 -8.07 -0.71 -7.03
% of Revenue 50.46 44.40 46.77 57.82 64.63 63.96 63.09 52.88 46.00 46.01 42.88 39.46 37.97 36.49 35.57 38.47 37.08 33.14 32.54 29.91
R&D 1 1 1 1 2 2 3 3 5 6 6 6 5 5 4 4 3 3 3 3
Change (%) -5.11 -10.40 -0.96 132.28 28.15 25.30 27.33 34.33 19.89 5.19 1.94 -11.52 -12.05 -9.79 -4.89 -13.63 -7.14 4.46 -1.68
% of Revenue 3.67 3.12 2.52 1.88 3.33 3.21 3.20 3.21 3.49 3.79 3.54 3.13 2.44 2.05 1.80 1.67 1.42 1.28 1.32 1.29
OpEx 34 34 38 54 74 99 126 151 177 197 215 239 265 270 273 283 280 275 276 272
Change (%) 0.97 10.83 41.80 38.65 33.72 26.98 19.52 17.30 11.09 9.21 11.44 10.73 1.85 1.09 3.72 -1.20 -1.50 0.18 -1.57
% of Revenue 144.21 130.24 130.33 139.18 147.15 148.04 149.37 140.75 133.47 134.56 130.33 125.87 122.76 119.84 117.88 118.70 115.61 110.73 109.70 106.77
Operating Income -10 -8 -9 -15 -24 -32 -42 -44 -44 -50 -50 -49 -49 -45 -41 -45 -38 -27 -24 -17
Change (%) -23.52 11.07 71.53 57.81 35.43 29.34 4.70 1.60 13.77 -1.04 -1.58 -0.11 -9.06 -7.38 7.74 -15.33 -29.30 -8.56 -29.48
% of Revenue -44.21 -30.24 -30.33 -39.18 -47.15 -48.04 -49.37 -40.75 -33.47 -34.56 -30.33 -25.87 -22.76 -19.84 -17.88 -18.70 -15.61 -10.73 -9.70 -6.77
Interest Expense -0 -0 -0
Change (%) 600.00 85.71
% of Revenue -0.00 -0.02 -0.03
Net Income -10 -8 -9 -32 -40 -37 -44 -11 -11 -27 -26 -47 -38 -56 -50 -49 -51 -27 -27 -19
Change (%) -23.15 10.40 266.37 26.82 -7.82 18.39 -74.81 0.55 146.18 -3.01 78.08 -20.25 49.34 -10.62 -1.81 4.56 -46.93 -2.71 -28.54
% of Revenue -43.36 -29.80 -29.71 -81.97 -79.27 -54.97 -51.72 -10.27 -8.35 -18.66 -16.05 -24.77 -17.40 -24.90 -21.66 -20.64 -21.28 -10.98 -10.56 -7.46

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista